Answers are grounded in this paper and cite their sources.
Research demonstrates the effectiveness of Ga68DOTATATE PET in differentiating schwannomas from SSTR2-expressing tumors, highlighting diagnostic potential.
Schwannomas exhibit minimal [Ga68]DOTATATE avidity, in contrast to SSTR2-expressing tumors such as meningiomas. [Ga68]DOTATATE PET may therefore aid in non-invasively differentiating schwannomas from SSTR2-expressing tumors with overlapping MRI features in diagnostically challenging cases.
No takes yet. Share an insight, caveat, or question.
Luck et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: